Longitudinal and cross-sectional studies suggest that a large number of obe
se patients have a high prevalence of hypertension. This association causes
the following changes: insulin and leptin resistance with a suppressed bio
logic activity of natriuretic peptide, which contributes to sodium retentio
n with concomitant expanded cardiopulmonary volume and increased cardiac ou
tput. The cellular metabolism of cations may be altered in obesity and may
lead to changes in vascular responsiveness and increased vascular resistanc
e. These changes lead to structural adaptations in the heart characterized
by concentric-eccentric left ventricular hypertrophy. The hypertrophic cond
ition provides the basis for the development of congestive heart failure an
d cardiac arrhythmias that may explain the higher rates of cardiac sudden d
eath in those patients. In the kidneys, obesity hypertension may initiate a
derangement of renal function. The increased deposit of interstitial cells
and of extracellular matrix between the tubules induces higher interstitia
l hydrostatic pressure and tubular sodium reabsorption. The consequent incr
ease in renal now and glomerular filtration enhances albuminuria excretion
and the susceptibility to the development of renal damage. In summary, the
hemodynamic and structural adaptations related to obesity hypertension is t
he cause of greater risk for adverse cardiovascular and renal events. Am J
Hypertens 2000;13:1308-1314 (C) 2000 American Journal of Hypertension, Ltd.